How to Store GLP-3/RT: Temperature, Shelf Life & Handling
Storage requirements for GLP-3/RT follow from what the molecule actually is — lipidated single-chain triple receptor agonist (gip / glp-1 / glucagon). The conditions below reflect that chemistry rather than generic peptide guidance.
Overview
Freezer for the powder, fridge once mixed, and it holds four to six weeks — longer than most peptides here. The same fatty chain that makes it last a long time in the body also makes it fairly durable in a vial. Do not freeze it once mixed.
What GLP-3/RT actually is
GLP-3/RT is an engineered molecule built to act on three receptors at once, all belonging to the system of hormones your gut releases around eating. Getting one chain to fit three different targets well is a genuinely hard design problem, which is why molecules like this appeared years after simpler ones.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Storage conditions for GLP-3/RT
Why these conditions, specifically
GLP-3/RT fails by physical aggregation far more readily than by chemical degradation. That inverts the usual priority: gentle handling matters more than light protection.
The main route to be aware of: interfacial aggregation from agitation, foaming, or freeze–thaw — the primary practical failure mode for this molecule class.
All 3 degradation routes for GLP-3/RTFreeze–thaw
Avoid freezing reconstituted material. For lipidated peptides the freeze–thaw risk is aggregation at the ice–liquid interface rather than chemical breakdown, and aggregation is not reversible on rewarming.
What GLP-3/RT is studied for
The defining feature: simultaneous GIP, GLP-1, and glucagon receptor activity from one chain.
Glucagon-receptor activity is studied for its contribution to energy expenditure, distinguishing triagonists from dual agonists.
Investigated in metabolic research models for effects on glucose homeostasis.
A major focus of the preclinical literature on this compound class.
Summarizes published preclinical literature — see the selected references below. Provided for research reference only; not a claim of efficacy or a description of human use.
- Jastreboff AM, Kaplan LM, Frías JP, et al. Triple–Hormone-Receptor Agonist GLP-3/RT for Obesity — A Phase 2 Trial. N Engl J Med. 2023.
- Browse current GLP-3/RT literature on PubMed
References describe in-vitro and preclinical research and are listed for reference only — not evidence of efficacy and not a description of human use.
More GLP-3/RT reference
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Storage reference for other compounds
Reviewed for research-use compliance by Kobi Williams, Founder — Popular Peptides Canada. Last reviewed 22 July 2026.
GLP-3/RT is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.